Although the detailed etiology of AD remains unclear, the mainstream belief now is that the widespread accumulation of Aβ peptide in the brain is an initial and pivotal event in the progression of AD, further eliciting a series of detrimental cascades, including tau pathology, chronic inflammation, and cognitive malfunction [4–7]. The gene discussed is MAPT; the disease is Alzheimer disease.